Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran.

Yilmaz A, Sert DE, Kocabeyoglu SS, Uguz E, Gül EB, Akkaya BB, Kervan U, Catav Z.

DOI: 10.5830/cvja-2026-015
Published: 2026-07-03
Container: Cardiovasc J Afr
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5830/cvja-2026-015,
  title = {Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran.},
  author = {Yilmaz A and  Sert DE and  Kocabeyoglu SS and  Uguz E and  Gül EB and  Akkaya BB and  Kervan U and  Catav Z.},
  year = {2026},
  journal = {Cardiovasc J Afr},
  doi = {10.5830/cvja-2026-015},
  url = {https://doi.org/10.5830/cvja-2026-015}
}

RIS

TY  - JOUR
TI  - Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran.
AU  - Yilmaz A
AU  -  Sert DE
AU  -  Kocabeyoglu SS
AU  -  Uguz E
AU  -  Gül EB
AU  -  Akkaya BB
AU  -  Kervan U
AU  -  Catav Z.
PY  - 2026
JO  - Cardiovasc J Afr
DO  - 10.5830/cvja-2026-015
UR  - https://doi.org/10.5830/cvja-2026-015
ER  -

APA

A, Y., DE, S., SS, K., E, U., EB, G., BB, A., U, K., & Z., C. (2026). Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran.. Cardiovasc J Afr. https://doi.org/10.5830/cvja-2026-015

Source records

europe-pmc · retrieved 2026-11-10T08:30:41.936Z